Bitnomial Launches First U.S. Regulated Injective Futures for Investors
Bitnomial Unveils First Regulated Injective (INJ) Futures in the U.S.
Chicago, April 15, 2026 – In a significant advancement for digital asset trading, Bitnomial Exchange, LLC, has announced the launch of the first U.S.-regulated Injective (INJ) futures. This strategic move, sanctioned by the Commodity Futures Trading Commission (CFTC), aims to give both institutional and retail traders a secure platform to gain exposure to INJ price movements, facilitating hedging and portfolio diversification.
The newly introduced Injective futures are crypto-settled and come with monthly expirations. Traders have the option to post collateral in either cryptocurrency or USD through Bitnomial Clearinghouse, LLC. This flexible margining system is designed to accommodate a wide spectrum of trading strategies and preferences.
Michael Dunn, President of Bitnomial Exchange, emphasized the technical prowess of Injective, stating, "Injective has built one of the more technically ambitious Layer 1 blockchains in the market with an on-chain order book, cross-chain execution capabilities, and minimal gas fees. These features have been meticulously designed with financial applications in mind." He reflected on how the introduction of INJ futures serves as a regulated instrument for traders to express their market views and aids in the pursuit of a potential spot ETF under the SEC's generic listing standards.
Moreover, Eric Chen, Co-Founder of Injective, commented on the importance of regulated U.S. derivatives markets, asserting that they are crucial for fostering broader institutional engagement in digital assets. Chen noted, "The launch of INJ futures on Bitnomial's CFTC-regulated platform signifies a growing interest for institutional-grade participation in the Injective ecosystem and encourages a wider range of market participants to connect with the network."
Injective’s blockchain is specifically designed for financial applications, showcasing features such as sub-second transaction finality and interoperability across various blockchain networks including IBC, Ethereum, and Solana. Notably, the protocol has attracted significant institutional validators, including prominent tech and finance players like Google Cloud and Binance. Additionally, Canary Capital has submitted a proposal to the SEC for a staked INJ ETF, highlighting further market interest in Injective derivatives.
With the inclusion of INJ futures, Bitnomial is expanding its lineup to encompass a diverse array of digital asset derivatives. The exchange already boasts the broadest range of underlying crypto assets in the U.S. derivatives market. The contracts will settle in cryptocurrency, allowing for a level of capital efficiency that traditional cash-only platforms often cannot provide. Following this launch, Bitnomial plans to introduce INJ perpetual futures and options, broadening the trading opportunities available to users.
Currently, INJ futures are exclusively available for institutional clients, with retail traders expected to gain access through Botanical, Bitnomial's dedicated retail trading platform, within the upcoming weeks. All futures contracts offered on Bitnomial Exchange LLC will be governed by the company's trading rules, ensuring a secure and compliant trading environment.
In summary, the introduction of INJ futures marks a milestone in the integration of digital assets into regulated financial markets. With Bitnomial leading the charge—providing an innovative trading framework for both retail and institutional investors—the future of digital asset trading looks promising.
About Bitnomial
Bitnomial, Inc., headquartered in Chicago, operates an exchange alongside a clearinghouse and a brokerage, all of which are regulated by the CFTC. Known for launching the first U.S. perpetuals, physical futures, and options associated with cryptocurrencies, Bitnomial has positioned itself as a pioneer in U.S. derivatives trading for digital assets, including offerings on BTC, XRP, ADA, and USDC, among others.